| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/13/2006 | CN1274675C Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105671 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes |
| 09/12/2006 | US7105669 Quinazoline derivatives |
| 09/12/2006 | US7105668 Methods and compositions utilizing quinazolinones |
| 09/12/2006 | US7105563 5-ureido-3-[(4-(3-methoxyphenyl)pyrrol-2-yl)methylene]indolin-2-one and derivatives; inhibition of phosphoinositide-dependent kinase-1 (PDK-1). |
| 09/12/2006 | US7105549 Aryl substituted pyridines and the use thereof |
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105543 4-, 5-, 6- and 7-indole derivatives useful for the treatment of CNS disorders |
| 09/12/2006 | US7105542 Chromone compound; also viricide, antiinflammatory agents |
| 09/12/2006 | US7105537 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105527 such as beta-D-N4-p-bromobenzoyl-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine; for treating human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections |
| 09/12/2006 | US7105526 Benzimidazole derivatives |
| 09/12/2006 | US7105522 Aids therapy; viricides |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105513 Cardiovascular disorders; strokes; hypotensive agents |
| 09/12/2006 | US7105509 Benzodiazepine derivatives as APP modulators |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105505 Benzimidazole derivatives useful as histamine H3 antagonists |
| 09/12/2006 | US7105503 Pyrazole compounds |
| 09/12/2006 | US7105482 Administering {(3R, 4S, 5S, 6R)-5-Methoxy-4-[(2R, 3R)-2-methyl-3-(3-methyl-but-2-enyl)-oxiranyl]-1-oxa-spiro[2.5]oct-6-yloxycarbonylamino}-3-methyl-butyric acid methyl ester; parasitic infections, thymoma, and lymphoid malignancies; prevents the metabolic degradation of the angiogenesis inhibitor |
| 09/12/2006 | US7105471 Arylphenyl-substituted cyclic ketoenols |
| 09/12/2006 | CA2315110C Pellets having a core coated with an antifungal and a polymer |
| 09/12/2006 | CA2235986C Inhibitors of protein isoprenyl transferases |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/11/2006 | CA2500676A1 Preparation of acid addition salts of amine bases by solid phase-gas phase reactions |
| 09/08/2006 | WO2006094237A2 Acridine and quinoline dervatives as sirtuin modulators |
| 09/08/2006 | WO2006093853A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006092731A1 1, 2, 4-triazole derivatives and their use as oxytocin antagonists |
| 09/08/2006 | WO2006092599A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 09/08/2006 | WO2006092493A1 $g(b) crystalline form of ivabradine hydrochloride, preparation method thereof and pharmaceutical compositions containing same |
| 09/08/2006 | WO2006092037A1 Process for producing atorvastatin hemicalcium |
| 09/08/2006 | WO2005086700A3 Hiv integrase inhibitors |
| 09/08/2006 | CA2600933A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 09/08/2006 | CA2600287A1 Use of cinnamoyl compound |
| 09/08/2006 | CA2599992A1 Acridine and quinoline dervatives as sirtuin modulators |
| 09/08/2006 | CA2599588A1 Crystalline and amorphous 4-cyano-n{(2r)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-n-pyridin-2-yl-benzamide hydrochloride |
| 09/07/2006 | US20060199966 Indol-2-amides as glycogen phosphorylase inhibitors |
| 09/07/2006 | US20060199964 preparation of 6-haloalkyl-3-nicotinic acid esters and also to novel enamine intermediates |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | US20060199821 Heterocyclic amides and sulfonamides |
| 09/07/2006 | US20060199818 Inhibiting the activity of a 5-hydroxytryptamine 2A by administering a N-heterocyclyl (preferably 1,3-dioxan-5-yl)-4-[(N-substituted)(hetero)arylamino]piperidine in which the N-substituant is arylalkanoyl, arylthioalkanoyl, arylalkylaminocarbonyl or arylalkylaminothiocarbonyl group |
| 09/07/2006 | US20060199789 medical composition |
| 09/07/2006 | DE102005010000A1 Indane Indanes |
| 09/06/2006 | EP1698628A1 Hydroxypyrimidinone derivative having hiv integrase inhibitory activity |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698626A1 Amidopyrazole derivative |
| 09/06/2006 | EP1698620A1 Benzene compounds disubstituted with cyclic groups at the 1- and 2-positions |
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | EP1697375A2 Heterocyclic protein kinase inhibitors and uses thereof |
| 09/06/2006 | EP1697352A2 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 09/06/2006 | EP1697351A1 2,6-bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 09/06/2006 | EP1697350A1 Tricyclic steroid hormone nuclear receptor modulators |
| 09/06/2006 | EP1697349A1 Doxepin analogs and methods of use thereof |
| 09/06/2006 | EP1697348A1 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697347A1 5- or 6-substituted benzimidazole derivatives as inhibitors of respiratiory syncytial virus replication |
| 09/06/2006 | EP1697343A1 Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication |
| 09/06/2006 | EP1697327A1 Insecticidal spiroindane derivatives |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/06/2006 | EP1697307A1 Opioid receptor antagonists |
| 09/06/2006 | EP1696931A2 Amino substituted diaryl [a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
| 09/06/2006 | EP1696924A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1562935B1 Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors |
| 09/06/2006 | EP1455579B1 Pyrazoles-pyrimidine fungicides |
| 09/06/2006 | EP1406609B1 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 09/06/2006 | EP1223933B1 5-membered heterocycle derivatives and use thereof as monoaminoxidase inhibitors |
| 09/06/2006 | EP1135374B1 Benzimidazole compounds that are vitronectin receptor antagonists |
| 09/06/2006 | CN1829711A Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 09/06/2006 | CN1829709A Bicyclic imidazol derivatives against flaviviridae |
| 09/06/2006 | CN1829701A Piperazine derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829698A Pyridazine derivatives and their use as therapeutic agents |
| 09/06/2006 | CN1829695A Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/06/2006 | CN1829688A Process and intermediate compounds useful in the preparation of statins, particularly atorvastatin |
| 09/06/2006 | CN1829516A S 2-'4(phenylamino)-piperidin-1-yl!-n-phenyl-acetamine derivatives and related compounds as neuropeptide y5 (npy5) ligands for the treatement of obesity |
| 09/06/2006 | CN1829512A Medicinal composition containing triazole compound |
| 09/06/2006 | CN1829507A 酪氨酸激酶抑制剂 Tyrosine kinase inhibitor |
| 09/06/2006 | CN1829506A Novel coumarin-amide derivatives and its preparation, its drug composition and use |
| 09/06/2006 | CN1827617A Antivirus use of 17-(tetrahydrofuryl-2'-yl) methyl amine-17-demethoxy geldanamycin |
| 09/06/2006 | CN1827616A Synthesis and uses of indole analogs of 1-benzyl-3-(5'-hydroxymethy 1-2' -furyl) indazole |
| 09/06/2006 | CN1827600A Crystalline form beta of the chlorhydrate of ivabradine, process for its preparation and pharamcetuical composition containing it |
| 09/06/2006 | CN1827108A Use of cytosine derivative for preparing drug for treating cancer |
| 09/06/2006 | CN1273468C One step preparation method of paluxitin hydrochloride A crystal type crystal molecule assembly |
| 09/06/2006 | CN1273467C Beta-lactam compounds, process for producing the same and serum cholesterol-lowering agents containing the same |
| 09/06/2006 | CN1273454C New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 09/06/2006 | CN1273451C Piperidine MCH antagonists and their use in treatment of obesity |
| 09/06/2006 | CN1273450C 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6ligands |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/05/2006 | USRE39265 Heteroarylpiperidines, and their use as antipsychotics and analgetics |
| 09/05/2006 | USRE39263 2-2-fluoro-5-ethylsulphonylamino-4-thiocarbamoyl-phenyl)-5,6,7,8-tetrahydro-1,2,4triazolo[4,3-a]pyridin-3(2H)-one; post or preemergent |
| 09/05/2006 | US7102009 For treating cancer and angiogenesis-related disorders |
| 09/05/2006 | US7102008 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| 09/05/2006 | US7101902 2-guanidinylimidazolidinedione compounds and methods of making and using thereof |
| 09/05/2006 | US7101898 Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 09/05/2006 | US7101896 Pharmaceutical compositions and methods for use |